French Neurovascular Society – Société Française Neuro-Vasculaire (SFNV)

🧠 We are delighted to share our experience at the 30th congress of the French Neurovascular Society (SFNV) held in Dijon from 19 to 21 November 2025.

💬 Dr. Jean-Baptiste Bertrand, Head of Clinical Operations, and Dr. Manuel Blanc, CEO of Lys Therapeutics, both participated in this year’s congress. They engaged in high-level scientific and clinical discussions, exploring new avenues for collaboration and addressing key challenges in neurovascular disease management.

🤝 At Lys Therapeutics, we remain committed to advancing innovative solutions and forging strong partnerships to shape the future of neurovascular care, fully aligned with our pipeline-in-a-drug strategy.